30-Day Average Daily Volume Chart

View 30-Day Average Daily Volume for VRTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View 30-Day Average Daily Volume Chart
Start Trial

Historical 30-Day Average Daily Volume Data

View and export this data back to 1991. Start Trial.
Date Value
August 27, 2026 1.258M
August 26, 2026 1.276M
August 25, 2026 1.287M
August 24, 2026 1.298M
August 21, 2026 1.311M
August 20, 2026 1.323M
August 19, 2026 1.358M
August 18, 2026 1.386M
August 17, 2026 1.412M
August 14, 2026 1.426M
August 13, 2026 1.450M
August 12, 2026 1.469M
August 11, 2026 1.493M
August 10, 2026 1.526M
August 07, 2026 1.726M
August 06, 2026 1.744M
August 05, 2026 1.761M
August 04, 2026 1.755M
August 03, 2026 1.756M
July 31, 2026 1.805M
July 30, 2026 1.824M
July 29, 2026 1.832M
July 28, 2026 1.833M
July 27, 2026 1.807M
July 24, 2026 1.794M
Date Value
July 23, 2026 1.789M
July 22, 2026 1.774M
July 21, 2026 1.770M
July 20, 2026 1.784M
July 17, 2026 1.792M
July 16, 2026 1.792M
July 15, 2026 1.785M
July 14, 2026 1.782M
July 13, 2026 1.809M
July 10, 2026 1.816M
July 09, 2026 1.807M
July 08, 2026 1.765M
July 07, 2026 1.747M
July 06, 2026 1.718M
July 02, 2026 1.727M
July 01, 2026 1.705M
June 30, 2026 1.706M
June 29, 2026 1.691M
June 26, 2026 1.658M
June 25, 2026 1.408M
June 24, 2026 1.404M
June 23, 2026 1.395M
June 22, 2026 1.386M
June 18, 2026 1.356M
June 17, 2026 1.296M

30-Day Average Daily Volume Range, Past 5 Years

View 30-Day Average Daily Volume Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

30-Day Average Daily Volume Benchmarks

View 30-Day Average Daily Volume Benchmarks
Start Trial
Gilead Sciences, Inc. 6.391M
Alnylam Pharmaceuticals, Inc. 2.034M
Regeneron Pharmaceuticals, Inc. 778928.9
Sionna Therapeutics, Inc. 3.252M
Biogen, Inc. 893594.0